secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001104659-26-027814
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar Board authorizes $50M increase to share buyback program
-----------------------------------------------------------------

- Board authorized $50M increase to buyback program on March 12, 2026.
- Program has indefinite duration; primary goal is offsetting dilution from equity compensation.
- Purchases may be via open market, block trades, Rule 10b5-1 plans, or private transactions.
- Timing and number of shares depend on price, regulatory requirements, and other conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000110465926027814/0001104659-26-027814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000110465926027814/amph-20260312x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-027814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer